What is Avania?
Avania operates as a comprehensive CRO, dedicated to advancing medical technology by managing clinical studies for a diverse range of products including medical devices, in vitro diagnostics (IVDs), biologics, and device-drug combination products. The company offers a customized approach, supporting products throughout their entire lifecycle, from initial human trials to commercialization and ongoing post-market monitoring. Avania's core mission is to serve as a trusted global partner, facilitating the evolution of medical innovations and ultimately improving patient health and well-being.
How much funding has Avania raised?
Avania has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
What's next for Avania?
With the recent influx of capital and a history of substantial debt financing, Avania is well-positioned for accelerated expansion and enhanced service offerings. The enterprise-level backing suggests a strategic focus on scaling operations, potentially through further technological integration, global market penetration, or acquisitions. This financial momentum is expected to bolster Avania's capacity to manage an increasing volume of complex clinical trials, reinforcing its role as a key player in the medical device development ecosystem and driving further innovation in patient care.
See full Avania company page
